drugset / Trial / NCT01845142

Immunologic Action of a Single Dose Cholecalciferol

NCT01845142

Phase 4 Completed 40 enrolled Margitta Worm
RandomizedSingle-groupDouble-blindBasic science

Summary

Vitamin D receptors are expressed in activated different immune cells. It is not known, which immune cell type is targeted by exogenous vitamin D. Here, vitamin D-deficient individuals will receive once 100.000 I.U. vitamin D3 either intramuscular or subcutaneous in a double-blind placebo controlled setting. Immune cells will be monitored from the blood over time.

Timeline

Start
2013-02
Primary completion
2013-05
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 100000 iu Intramuscular

Indications